The number of resected lymph nodes from the upper mediastinal area predicts long-term outcomes of esophageal squamous cell carcinoma after minimally invasive esophagectomy

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–42

Article  PubMed  Google Scholar 

Chen D, Wang W, Mo J, Ren Q, Miao H, Chen Y, Wen Z (2021) Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments. BMC Cancer 21:145

Article  PubMed  PubMed Central  Google Scholar 

Kayani B, Zacharakis E, Ahmed K, Hanna GB (2011) Lymph node metastases and prognosis in oesophageal carcinoma - a systematic review. Euro J Surg Oncol 37:747–53

Article  CAS  Google Scholar 

Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM (2002) Prognostic factors for the survival of patients with esophageal carcinoma in the U.S. The importance of tumor length and lymph node status. Cancer 95:1434–43

Article  PubMed  Google Scholar 

Kranzfelder M, Schuster T, Geinitz H, Friess H, Büchler P (2011) Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Br J Surg 98:768–83

Article  CAS  PubMed  Google Scholar 

Altorki NK, Zhou XK, Stiles B, Port JL, Paul S, Lee CP, Mazumdar M (2008) Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg 248:221–6

Article  PubMed  Google Scholar 

Peyre CG, Hagen JA, DeMeester SR, Altorki NK, Ancona E, Griffin SM, Hölscher A, Lerut T, Law S, Rice TW, Ruol A, van Lanschot JJ, Wong J, DeMeester TR (2008) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248:549–56

Article  PubMed  Google Scholar 

Tachimori Y, Ozawa S, Numasaki H, Matsubara H, Shinoda M, Toh Y, Udagawa H, Fujishiro M, Oyama T, Uno T, Registration Committee for Esophageal Cancer of the Japan Esophageal Society (2016) Efficacy of lymph node dissection by node zones according to tumor location for esophageal squamous cell carcinoma. Esophagus 13:1–7

Article  PubMed  Google Scholar 

Osugi H, Narumiya K, Kudou K (2017) Supracarinal dissection of the oesophagus and lymphadenectomy by MIE. J Thorac Dis 9:741–50

Article  Google Scholar 

Worrell SG, Bachman KC, Sarode AL, Perry Y, Linden PA, Towe CW (2020) Minimally invasive esophagectomy is associated with superior survival, lymphadenectomy and surgical margins: propensity matched analysis of the National Cancer Database. Dis Esophagus 33:10

Article  Google Scholar 

Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, Ikeda K, Kanda T, Tsujinaka T, Nakamura K, Fukuda H (2012) A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 19:68–74

Article  PubMed  Google Scholar 

Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, Zanchettin G, Rugge M, Ancona E (2011) Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Ann Surg Oncol 18:3743–54

Article  PubMed  Google Scholar 

Shridhar R, Hoffe SE, Almhanna K, Weber JM, Chuong MD, Karl RC, Meredith K (2013) Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy. Ann Surg Oncol 20:3038–43

Article  PubMed  Google Scholar 

Japan Esophageal Society (2017) Japanese classification of esophageal cancer, 11th edition: part I. Esophagus 14:1–36

Article  Google Scholar 

Koterazawa Y, Oshikiri T, Takiguchi G, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Nakamura T, Fujino Y, Tominaga M, Suzuki S, Kakeji Y (2019) Prophylactic cervical lymph node dissection in thoracoscopic esophagectomy for esophageal cancer increases postoperative complications and does not improve survival. Ann Surg Oncol 26:2899–904

Article  PubMed  Google Scholar 

Oshikiri T, Nakamura T, Miura Y, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Sumi Y, Suzuki S, Kakeji Y (2017) A new method (the “Pincers maneuver”) for lymphadenectomy along the right recurrent laryngeal nerve during thoracoscopic esophagectomy in the prone position for esophageal cancer. Surg Endosc 31:1496–504

Article  PubMed  Google Scholar 

Oshikiri T, Takiguchi G, Urakawa N, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y (2021) Novel “Modified Bascule Method” for lymphadenectomy along the left recurrent laryngeal nerve during robot-assisted minimally invasive esophagectomy. Ann Surg Oncol 28:4918–27

Article  PubMed  Google Scholar 

Oshikiri T, Yasuda T, Kawasaki K, Harada H, Oyama M, Hasegawa H, Ohara T, Sendo H, Nakamura T, Fujino Y, Tominaga M, Kakeji Y (2016) Hand-assisted laparoscopic surgery (HALS) is associated with less-restrictive ventilatory impairment and less risk for pulmonary complication than open laparotomy in thoracoscopic esophagectomy. Surgery 159:459–66

Article  PubMed  Google Scholar 

Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–83

Article  CAS  PubMed  Google Scholar 

Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P (2017) Cancer of the esophagus and esophagogastric junction an eighth edition staging primer. J Thoracic Oncology 12:36–42. https://doi.org/10.1016/j.jtho.2016.10.016

Article  Google Scholar 

Kato K, Ito Y, Daiko H, Ozawa S, Ogata T, Hara H, Kojima T, Abe T, Bamba T, Watanabe M, Kawakubo H, Shibuya Y, Tsubosa Y, Takegawa N, Kajiwara T, Baba H, Ueno M, Machida R, Nakamura K, Kitagawa Y (2022) A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study. J Clin Oncol 40:238

Article  Google Scholar 

Kitagawa Y, Ishihara R, Ishikawa H, Ito Y, Oyama T, Oyama T, Kato K, Kato H, Kawakubo H, Kawachi H, Kuribayashi S, Kono K, Kojima T, Takeuchi H, Tsushima T, Toh Y, Nemoto K, Booka E, Makino T, Matsuda S, Matsubara H, Mano M, Minashi K, Miyazaki T, Muto M, Yamaji T, Yamatsuji T, Yoshida M (2023) Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 1. Esophagus 18:1–18

Google Scholar 

Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien–Dindo classification of surgical complication: 5-year experience. Ann Surg 250:187–96

Article  PubMed  Google Scholar 

Zhang X, Yang Y, Sun Y, Ye B, Guo X, Mao T, Hua R, Li B, Gu H, Liu J, Li Z (2019) Adjuvant therapy for pathological T3N0M0 esophageal squamous cell carcinoma. J Thorac Dis 11:2512–22

Article  PubMed  PubMed Central  Google Scholar 

Chen SB, Weng HR, Wang G, Yang JS, Yang WP, Liu DT, Chen YP, Zhang H (2013) Prognostic factors and outcome for patients with esophageal squamous cell carcinoma underwent surgical resection alone: evaluation of the seventh edition of the American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma. J Thorac Oncol 8:495–501. https://doi.org/10.1097/JTO.0b013e3182829e2c

Article  PubMed  Google Scholar 

Baba Y, Watanabe M, Shigaki H, Iwagami S, Ishimoto T, Iwatsuki M, Baba H (2013) Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma. Surgery 153:234–41

Article  PubMed  Google Scholar 

Oshikiri T, Goto H, Kato T, Hasegawa H, Kanaji S, Yamashita K, Fujino Y, Tominaga M, Matsuda T, Kakeji Y (2023) Improvement effect of upper mediastinal lymphadenectomy during minimally invasive esophagectomy on the prognosis in squamous cell carcinoma: efficacy index and propensity score matching analyses. J Am Coll Surg 237:762–70

Article  PubMed  Google Scholar 

Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JH, Hollmann MW, de Lange ES, Bonjer HJ, van der Peet DL, Cuesta MA (2012) Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 379:1887–92

Article  PubMed  Google Scholar 

Motoyama S, Maeda E, Yano M, Yasuda T, Ohira M, Kajiyama Y, Higashi T, Doki Y, Matsubara H (2020) Esophagectomy performed at institutes certified by the Japan Esophageal Society provide long-term survival advantages to esophageal cancer patients: second report analyzing 4897 cases with propensity score matching. Esophagus 17:141–8

Article  PubMed  PubMed Central  Google Scholar 

Motoyama S, Yamamoto H, Miyata H, Yano M, Yasuda T, Ohira M, Kajiyama Y, Toh Y, Watanabe M, Kakeji Y, Seto Y, Doki Y, Matsubara H (2020) Impact of certification status of the institute and surgeon on short-term outcomes after surgery for thoracic esophageal cancer: evaluation using data on 16,752 patients from the National Clinical Database in Japan. Esophagus 17:41–9

Article  PubMed  Google Scholar 

Zhao Y, Dai Z, Min W, Sui X, Kang H, Zhang Y, Ren H, Wang XJ (2015) Perioperative versus preoperative chemotherapy with surgery in patients with resectable squamous cell carcinoma of esophagus: a phase III randomized trial. J Thorac Oncol 10:1349–56

Article  CAS  PubMed  Google Scholar 

Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lièvre A, Uronis H, Elimova E, Grootscholten C, Geboes K, Zafar S, Snow S, Ko AH, Feeney K, Schenker M, Kocon P, Zhang J, Zhu L, Lei M, Singh P, Kondo K, Cleary JM, Moehler M, CheckMate 577 Investigators (2021) Adjuvant Nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med 384:1191–203

Article  CAS  PubMed  Google Scholar 

Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K, Japanese Society for Cancer of the Colon and Rectum (2020) Japanese Society for Cancer of the Colon and Rectum guideline 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25:1–42

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif